Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ribavirin Pregnancy Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by INC Research
Aurobindo Pharma
Genentech, Inc.
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Kadmon Pharmaceuticals, LLC
Information provided by (Responsible Party):
INC Research Identifier:
First received: June 16, 2005
Last updated: October 5, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2025
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)